Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. PPD's Total Liabilities for the quarter that ended in Sep. 2021 was $7,452 Mil. PPD's Total Assets for the quarter that ended in Sep. 2021 was $7,028 Mil.
Therefore, PPD's Liabilities-to-Assets Ratio for the quarter that ended in Sep. 2021 was 1.06.
PPD Liabilities-to-Assets Historical Data
The historical data trend for PPD's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PPD's Liabilities-to-Assets
For the Drug Manufacturers - Specialty & Generic subindustry, PPD's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PPD's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PPD's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where PPD's Liabilities-to-Assets falls into.
PPD Liabilities-to-Assets Calculation
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
PPD's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2020 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PPD (NAS:PPD) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
PPD Liabilities-to-Assets Related Terms
Thank you for viewing the detailed overview of PPD's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PPD has been successfully added to your 